View more job listings or post a job
Jazz Pharmaceuticals Senior Manager, Clinical Pharmacology
Nektar Therapeutics Research Associate III
Nektar Therapeutics Sr. Scientist, Bioanalytical
Genentech, Inc. Associate Scientist/Scientist, Drug Metabolism and Pharmacokinetics
Jubilant Discovery Services Senior Manager Business Development
Aimmune Therapeutics The Associate Director, Quality Control will be a key member of the analytical team and he/she will support activities associated with quality control activities of Aimmune’s APIs and drug products conducted at CTL/CMO.  
Precision for Medicine Senior Manager, Quality Assurance
Denali Therapeutics Bioanalytical Research Scientist, DMPK (SM/Biomarker)
Arena Pharmaceuticals The Principal Scientist will report to the Head of Analytical Sciences and will serve as the analytical lead in cross-functional product development tea
Genentech Associate Scientist/Scientist, Process Analytical Technology, Small Molecule Analytical Chemistry  
Post a job


Regulated Large Molecule Bioanalysis: Fundamentals, the New FDA Guidance and Beyond

Organizers: Rebecca Elliott, Weili Yan and Surinder Kaur (Genentech)
Date: 2020-05-12
Time: 8:45-17:00 Pacific Time
Registration fee (USD): Regular: $195; For unemployed or students: $30; Academic: $125; For major-sponsor rep (incl lunch): $0; For vendor-show rep: $35
Location: SF Bay Area: Foster City Crowne Plaza
Major Sponsor: (1)KCAS Bioanalytical & Biomarker Services;(Major Sponsorship - afternoon session still open)
Vendor show vendors registered to date: (2)BioAgilytix Labs; Mercodia
Registration deadline:2020-05-12  (it will close sooner if the seating cap is reached)

About the Topic

Validated bioanalytical methods for the quantitative evaluation of large molecule drugs and biomarkers in a given biological matrix are critical for the successful conduct of nonclinical and clinical studies. These validated methods under regulated GxP environment provide critical data to support the safety and effectiveness of drugs and biologic products. Ligand binding assays (LBA) and emerging new technologies are widely used for regulated large molecule bioanalysis.

The workshop includes an introduction to regulated bioanalytical method development/validation and sample testing, focusing on new FDA guidance and future global harmonized guidance for large molecule bioanalysis. Applying general bioanalytical principles to emerging new technologies and/or new drug entities such as cell and gene therapy to meet health authorities’ compliance requirements will also be presented by industry recognized experts.

The following topics will be covered:

  • Introduction: Fundamentals of large molecule bioanalysis- method development, regulated validation and sample testing
  • 2018 FDA bioanalytical method validation guidance, changes from previous guidance, future global harmonized guidance
  • Hybrid LBA/LC-MS bioanalytical method
  • New technologies in large molecule bioanalysis
  • Cross validation
  • Life cycle management of bioanalytical method (critical reagents)
  • Bioanalysis in gene and/or cell therapy
  • Method transfer, validation, production from CRO perspective

2019-11-12, Antibody Drug Discovery and Development: Hit Generation, Engineering, Cell-line Development, IND enabling studies, and Biosimilars
2019-12-10, In Vitro Diagnostics (IVD), Companion Diagnostics (CDx) and Precision Medicine
2020-01-10, All about half-life: which one should I use? (tentative title)
2020-01-21, Considerations for Successful Clinical Development: Fundamentals and Best Practices for Clinical Trial Design, Biostatistics, and Data Management
2020-02-11, Development of Drug/Device Combinations
2020-02-24, MS Courses by Dr. Jack Henion: Advanced LC-MS/MS (Day1) & Interpretation of MS/MS CID Spectra (Day2)
2020-03-16, Clinical Trials Essentials: An Intensive One-Week Course (register for the full week or half day sessions)
2020-04-10, Biopolymer-based conjugation of therapeutic proteins and antibodies for improving drug properties (tentative title)
2020-05-22, No More Undruggables: Unconventional Approaches for Drug Discovery and Design - prodrugs, PROTACS, fragment-based design, directed evolution and beyond
2020-06-23, Advances in Immuno-Oncology (A Joint Symposium by PBSS and BioScience Forum)
┬ęPharmaceutical & BioScience Society, International; Last Modified: 10/20/2019; Admin Logon
Ads (in random order)
Submit a Text Ad
($250 for 2 months)

UC Davis UC Davis LC/MS Confirmation Supervisor (Lab Rsch Supv 2) Apply Online: UC Davis is an AA/EOE
Origin Bioanalytical Laboratory Sacramento-based CRO for bioanalytical method development, validation, and consulting of LC-MS/MS analysis, specializing in ocular matrices
Alturas Analytics, Inc. Expert GLP & non-GLP LC-MS/MS & GC-MS/MS bioanalytical quantitation services of small & large molecules in any matrix. Discovery through phase IV.
XCELERATE at Biotech Week Boston Driving the Future of the Life Science Industry. Sept. 11 at BCEC. Learn more.
Adesis Inc. Adesis provides expertise in custom synthesis, process dev, R&D, and specialty mfg. to pharma, chemical, biomaterials, and catalysts companies
BIOTECH WEEK BOSTON - Sept. 9-12 Access over 5,000 of the most innovative scientific minds & business leaders in Boston and around the world. Learn More.
Submit a Text Ad